Genitourinary Symptoms With Levonorgestrel Releasing Intrauterine Systems

Genitourinary Symptoms in Women Using Levonorgestrel Releasing Intrauterine Systems

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01730300

Enrollment

Registered

2012-11-21

Start date

2012-06-30

Completion date

2013-05-31

Last updated

2013-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Urinary Tract Symptoms

Brief summary

The main purpose of the study was to evaluate the efficacy of Levonorgestrel Releasing Intrauterine devices (LNR-IUD) on genitourinary symptoms in patients with abnormal uterine bleeding. The patients were asked urogenital distress inventory (UDI) (which includes; irritative symptoms, stress symptoms, obstructive discomfort) and incontinence impact questionnaire (IIQ) (which includes; physical activity, travel, social/relationships, emotional health)questionnaires in the day of application LNR-IUD and six months later this procedure. Statistical analyse will be performed to evaluate the changes in this time period.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

15 Years to 55 Years

Healthy volunteers

Inclusion criteria

* women using levonorgestrel releasing intrauterine device for the treatment of menorrhagia or adenomyosis

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
Urinary frequency	6 months	We think that the urinary frequency will be lesser after 6 months of the therapy.

Secondary

Measure	Time frame	Description
social activity	6 months	We think that social activity will be better after reducing urinary symptoms

Countries

Turkey (Türkiye)

Outcome results